Feasibility study report on the production of liquid chromatography series separation equipment
, liquid chromatography series separation equipment production project market background
In China, the market size of liquid chromatography equipment in the R&D and manufacturing of chemical drugs has grown steadily. In 2017, the market size of China's small molecule liquid chromatography equipment (including production and laboratory use) (including the export revenue of domestic manufacturers) was about 1.4 billion yuan, and in 2022, it will reach 3 billion yuan, with a compound annual growth rate of 167%。It is expected that China's small molecule liquid chromatography equipment market will continue to grow in the future, reaching 5.4 billion yuan by 2026, with a compound annual growth rate of 157%。Among them, the market size of production-grade small molecule liquid chromatography systems in 2022 is 7400 million yuan, driven by the huge growth potential of the peptide drug market such as semaglutide, it is expected to reach 18400 million yuan, with a compound annual growth rate of 255%。
China Small Molecule Liquid Chromatography Equipment (chemical agents).Market size
, the policy environment of the production project of liquid chromatography series separation equipment
The release of the 14th Five-Year Plan for the Development of the Bioeconomy and the 14th Five-Year Plan for the Development of the Pharmaceutical Industry proposes to "focus on the development of ultra-large-scale (10,000-liter tank) cell culture technology, bifunctional antibodies, antibody drug conjugates, peptide drug conjugates, new recombinant protein vaccines, nucleic acid vaccines, cell and gene drugs and other new biological drugs for industrial preparation". In addition, the policy points out that enterprises should be supported to integrate scientific and technological resources, focus on key technologies, core equipment, and new materials for the production of drugs and medical devices, develop and transform a number of advanced technologies, and build new advantages in industrial technology. Focus on improving the production technology of new biological drugs, the innovative process of APIs, the production technology of high-end preparations, the whole process quality control technology of traditional Chinese medicine, the engineering technology of medical devices and the production technology of key components; Benchmark against the international advanced level, strengthen the support of resource elements, promote the upstream and downstream enterprises and scientific research units of the industrial chain to strengthen cooperation, carry out key technology product research, and make up for the key shortcomings of the industrial chain.
Analysis of the necessity of project construction
1) The construction of the project is the need to accelerate the process of industrial localization.
Expand the coverage of pharmaceutical equipment categories and application scenarios to provide continuous impetus for the growth of the company's business revenue. At present, China's production-grade macromolecule chromatography system market is still dominated by imported brands, mainly due to the fact that imported manufacturers entered the market earlier and performed better. With the increase in R&D investment and policy promotion, the competitiveness of domestic brands in terms of supply integrity, speed and accuracy is gradually improving. The company is committed to providing overall solutions for drug chromatography purification for biopharmaceutical enterprises, providing users with one-stop services from laboratory to industrial production, improving supply efficiency and improving supply integrity. The implementation of this project is conducive to the company to further improve the product capacity, enhance the service capacity, and improve the localization rate of the pharmaceutical equipment industry.
2) The construction of the project is the need to improve the competitiveness of enterprises.
Accelerate the application of innovative pharmaceutical equipment and consolidate the company's competitive advantage. In addition to advanced liquid chromatography systems and macromolecular chromatography systems, the company has also developed new chromatography equipment with technical characteristics such as simulated moving bed chromatography systems and supercritical fluid chromatography systems. The implementation of this project will help the company accelerate the improvement of the production capacity of new pharmaceutical equipment, so as to consolidate the company's leading position in the high-end pharmaceutical equipment industry.
3) The construction of the project is the need to promote local economic development.
After the completion of the project, it will increase the local tax revenue, directly increase the number of jobs, and radiate the demand for employment.
, investment estimates
Project Investment Estimate Form.
For more industry information, please refer to PwC Consulting"Feasibility Study Report on Liquid Chromatography Series Separation Equipment Production Project".At the same time, PwC Consulting also provides services such as industrial research reports, industrial chain consulting, project feasibility reports, specialized and special new little giant certification, 14th Five-Year Plan, post-project evaluation reports, BP business plans, industrial maps, industrial planning, national manufacturing single champion enterprise certification, IPO fundraising and investment feasibility studies, IPO working paper consulting and other services.